<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Neuroscience</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/570C2884-4776-4671-8B49-966FC4378AA1"><gtr:id>570C2884-4776-4671-8B49-966FC4378AA1</gtr:id><gtr:firstName>Claire</gtr:firstName><gtr:surname>Troakes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/41068207-27FE-4720-AF41-A707BEE62ACE"><gtr:id>41068207-27FE-4720-AF41-A707BEE62ACE</gtr:id><gtr:firstName>Ammar</gtr:firstName><gtr:surname>Al-Chalabi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9B8C6561-A7B1-4005-94C5-F62552C54593"><gtr:id>9B8C6561-A7B1-4005-94C5-F62552C54593</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Lovestone</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/62211B96-56AF-4672-8BA7-754E3F0AC07B"><gtr:id>62211B96-56AF-4672-8BA7-754E3F0AC07B</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>E</gtr:otherNames><gtr:surname>Shaw</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/05BF89CB-F4A6-4BD3-A566-CA7B0792F3B4"><gtr:id>05BF89CB-F4A6-4BD3-A566-CA7B0792F3B4</gtr:id><gtr:firstName>Safa</gtr:firstName><gtr:surname>Al-Sarraj</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1100695"><gtr:id>C152D52E-A0D2-4C6A-A5B1-0BCA2ABE8E90</gtr:id><gtr:title>London Neurodegenerative Diseases Brain Bank; a national resource for neuroscience research</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1100695</gtr:grantReference><gtr:abstractText>The Brain Bank collects post-mortem brain tissue from persons with neurodegenerative diseases, such as dementia and motor neuron disease. Wherever possible data from previous clinical examinations, neuropsychological tests and neuroimaging are also collected. The brain tissue is examined by neuropathologists and disease is diagnosed according to internationally agreed criteria. Samples of brain and spinal cord tissue in various fixation states, such as frozen and formalin-fixed, are then made available to Neuroscience researchers. The purpose of the project is to provide clinically studied and pathologically verified brain tissue to facilitate and promote internationally competitive research into Neurodegenerative disease. The Brain Bank aims are to fulfill international recommendations and guidelines with regard to brain tissue banking. As such, this involves the systematic and focused collection of well-characterised post-mortem material and its subsequent distribution to research groups both regionally and nationally. This will necessarily underpin high quality and peer-reviewed research. The following is a summary of the key functions of the Brain Bank: 1. To advance the understanding of, and facilitate research into the underlying causes of neurodegenerative and neurological diseases through the provision of clinically and neuropathologically well-characterised brain tissue to the research community. 2. To facilitate brain donation through an ethically approved programme of informed consent for donation. 3. To provide pathological diagnosis to the relatives of brain donors according to best national and international protocols. 4. To coordinate the processing and dissemination of well-preserved brain tissue and maintain an open door policy of responding to requesters without prejudice. 5. To ensure donor care and keep contact with brain donor families, informing them about diagnosis and progress in research. 6. To disseminate and promote knowledge of brain banking through scientific meetings, public open days, collaboration with charities and MRC newsletters. 7. To provide professional teaching, training, information and educational resources for neuroscientists and medical trainees. 8. To facilitate collaboration between basic research scientists, pathologists and clinicians to promote transitional research to help develop new diagnostic and therapeutic strategies for brain diseases. 9. To maintain gold standards of excellence in Brain Banking for storage of frozen and formalin-fixed brain tissue. 10. To follow most recent ethical principles for best practice in Brain Banking, from consenting donors to tissue requests and strictly follow the guidelines of the Human Tissue Act.</gtr:abstractText><gtr:technicalSummary>Clincally assessed and neuropathologically characterised human post-mortem brain and spinal cord tissue is one of the most important resources for research into neurodegeneration. Continued access to high quality tissue is vital for the development of current research strategies and future clinical treatments. There has been significant research progress during the last three decades, which has increased demand for brain tissue from brain banks. The London Neurodegenerative Diseases Brain Bank at the IOP has become a leader in the field of brain banking and a major source of high quality brain tissue, not only for researchers at the IOP and elsewhere in London but throughout the UK and worldwide and has thus contributed to the success of many research studies. Material from the Brain Bank is also essential for the progress of a number of on-going research programmes. The aim of the Brain Bank is to achieve gold standard in brain banking through programmed brain donation, including regulated ad-hoc donations, following best practice in ethical matters relating to consenting, donor family care, high standards of storage of brain tissue and easy access to tissue for researchers. We aim to continue to focus our banking on neurodegenerative diseases including MND/FTLD and movement disorders, Alzheimer s disease and related dementias and vascular dementia but also to facilitate other collections, such as psychosis, traumatic brain injury (to study it s relation to neurodegeneration) and paediatric disorders in order to enhance research in these areas. The ultimate goal is to contribute to understanding the mechanisms of neurodegeneration, in order to prepare the way for new scientifically based treatments and preventions as well as play an integral part in clinical studies and the evaluation of clinical trials.</gtr:technicalSummary><gtr:fund><gtr:end>2013-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>495805</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Oxford Centre for Human Brain Activity (OHBA)</gtr:department><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>B070F803-B68E-4161-B745-89598CFA96C1</gtr:id><gtr:impact>Increased numbers of brain donors, who will have thourough clinical assesments prior to donation.</gtr:impact><gtr:outcomeId>nJs1aTHB9xw-2</gtr:outcomeId><gtr:partnerContribution>Collaborative research projects, sharing of tissueCollaborative Research projects and sharing of tissueCollaborative research projects and sharing of tissueCollaborative research projects and sharing of tissue</gtr:partnerContribution><gtr:piContribution>Projects are ongoing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute for Ageing and Health</gtr:department><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>707889BE-D2E2-4865-866F-88E362EC76A2</gtr:id><gtr:impact>Increased numbers of brain donors, who will have thourough clinical assesments prior to donation.</gtr:impact><gtr:outcomeId>nJs1aTHB9xw-3</gtr:outcomeId><gtr:partnerContribution>Collaborative research projects, sharing of tissueCollaborative Research projects and sharing of tissueCollaborative research projects and sharing of tissueCollaborative research projects and sharing of tissue</gtr:partnerContribution><gtr:piContribution>Projects are ongoing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>06C1113E-3D65-49C9-82C5-5C0663119458</gtr:id><gtr:impact>Increased numbers of brain donors, who will have thourough clinical assesments prior to donation.</gtr:impact><gtr:outcomeId>nJs1aTHB9xw-5</gtr:outcomeId><gtr:partnerContribution>Collaborative research projects, sharing of tissueCollaborative Research projects and sharing of tissueCollaborative research projects and sharing of tissueCollaborative research projects and sharing of tissue</gtr:partnerContribution><gtr:piContribution>Projects are ongoing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>F3DD10DC-38B8-4758-BC96-A4104AE495DC</gtr:id><gtr:impact>Increased numbers of brain donors, who will have thourough clinical assesments prior to donation.</gtr:impact><gtr:outcomeId>nJs1aTHB9xw-4</gtr:outcomeId><gtr:partnerContribution>Collaborative research projects, sharing of tissueCollaborative Research projects and sharing of tissueCollaborative research projects and sharing of tissueCollaborative research projects and sharing of tissue</gtr:partnerContribution><gtr:piContribution>Projects are ongoing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Community-Based Medicine</gtr:department><gtr:description>Brains for Dementia Research</gtr:description><gtr:id>2012575B-1D1B-4583-B50A-A46E87FF08FF</gtr:id><gtr:impact>Increased numbers of brain donors, who will have thourough clinical assesments prior to donation.</gtr:impact><gtr:outcomeId>nJs1aTHB9xw-1</gtr:outcomeId><gtr:partnerContribution>Collaborative research projects, sharing of tissueCollaborative Research projects and sharing of tissueCollaborative research projects and sharing of tissueCollaborative research projects and sharing of tissue</gtr:partnerContribution><gtr:piContribution>Projects are ongoing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Pint of Science talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D70E8F7A-F9E1-4711-9415-43EA4BA63AE0</gtr:id><gtr:impact>Team member gave a talk for the 'Pint of Science' series in a London pub to approx. 50 people</gtr:impact><gtr:outcomeId>58de6715c3a911.91752135</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9A96F363-CD63-412E-B83B-D5392060B0F1</gtr:id><gtr:impact>Public lecture on the genetics and biology of motor neuron disease</gtr:impact><gtr:outcomeId>58c93f4e8924f4.27061276</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture on motor neuron disease research</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D6995F84-6312-4B9B-8B98-B1147A6B2C6D</gtr:id><gtr:impact>I spoke at a dinner hosted by the MND Association for major donors at the Royal Institution</gtr:impact><gtr:outcomeId>58c93ff0bc3547.27040784</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>St Georges hospital talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3EF0E9CA-A34C-47F7-AAAF-368BDA556EAE</gtr:id><gtr:impact>20 early onset dementia patients/carers attended a talk on the work of the brain bank

some new donors registered</gtr:impact><gtr:outcomeId>e8sXLupiLdA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to forensic neuropathologists</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9211AEA3-C8D7-4B0B-B5D4-66E757A30DAD</gtr:id><gtr:impact>Discussion on collaboration to increase donations of head injury and control

N/A</gtr:impact><gtr:outcomeId>HKJAMoHGWAg</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IOP Open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D17ECC39-AFFE-4B2A-BB16-6133F9B11F43</gtr:id><gtr:impact>6 groups attended a talk on the work of the brain bank

increased interest and registrations as donors, feedback from those who attended was excellent</gtr:impact><gtr:outcomeId>pZm3379NjSV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Ask the Experts Panel at International Symposium</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>93EA08C8-0B29-48B0-993B-85CF78ACE0FE</gtr:id><gtr:impact>A live audience and online audience watched a presentation and then asked questions on ALS research</gtr:impact><gtr:outcomeId>58a2ec3fab4506.37085934</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=U98WU4Zzu8s</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MNDA information video on our research</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B5834775-98CD-449D-88B2-DDA305B5B4FA</gtr:id><gtr:impact>A YouTube video posted also on the Motor Neurone Disease Association website, describing our research.</gtr:impact><gtr:outcomeId>58a2eb299868a4.07244144</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://youtu.be/tKz81aFVB04</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IOP Public open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2B9BE10D-D44A-4E90-A671-6C0AED813AB0</gtr:id><gtr:impact>New registrations

open day oversubscribed, feedback from those who attended was excellent</gtr:impact><gtr:outcomeId>pGyQkPidB4L</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>General research dissemination videos on YouTube</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B8AC9C47-DAF7-435C-AEF1-6E1BFAF7291F</gtr:id><gtr:impact>Multiple videos on YouTube, responding to interviews on ALS research</gtr:impact><gtr:outcomeId>58a2ed187db8e3.61005635</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.youtube.com/results?search_query=ammar+al-chalabi+als</gtr:url><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>King's Biomedical Sciences Institute PhD Studentship</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>King's College London</gtr:fundingOrg><gtr:id>4B803F91-31A4-4F0C-99A4-24AD4E9C0D7D</gtr:id><gtr:outcomeId>58c93d5ceb05d9.47554176</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>44B489DA-8E83-4563-B1B1-87A7820EB6AF</gtr:id><gtr:title>Simulated surgical-type cerebral biopsies from post-mortem brains allows accurate neuropathological diagnoses in the majority of neurodegenerative disease groups.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/260fa42b858aee5033974fabe5a89dd6"><gtr:id>260fa42b858aee5033974fabe5a89dd6</gtr:id><gtr:otherNames>King A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>54621f82e4c627.54770437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD1191D0-29AF-4644-92DE-F5009B1884A2</gtr:id><gtr:title>TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets.</gtr:title><gtr:parentPublicationTitle>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f5ee2d92393641a7087d03d8fb52781"><gtr:id>2f5ee2d92393641a7087d03d8fb52781</gtr:id><gtr:otherNames>Scotter EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1878-7479</gtr:issn><gtr:outcomeId>56d46237093897.21473834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1659BD5B-0013-46A2-97F2-0B9BEC250DB9</gtr:id><gtr:title>Novel mutations support a role for Profilin 1 in the pathogenesis of ALS.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5675ddabd33ae</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E15914A8-649A-4B16-B497-59BF01701070</gtr:id><gtr:title>In vitro prion-like behaviour of TDP-43 in ALS.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f81eaa813c262feb0e690df5c6269148"><gtr:id>f81eaa813c262feb0e690df5c6269148</gtr:id><gtr:otherNames>Smethurst P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>58db930f57e848.89148102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09D5BB1C-A6CE-4472-B59D-795BDA59F24C</gtr:id><gtr:title>Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/648ce689029eb74519bb3610828d1173"><gtr:id>648ce689029eb74519bb3610828d1173</gtr:id><gtr:otherNames>van Eijk RPA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5aa699e5ebbea6.81534669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDF70AAD-EC1D-4099-A7A1-FF709537FC10</gtr:id><gtr:title>Tar DNA-binding protein-43 (TDP-43) regulates axon growth in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0737bcb5a8ebef94755f6214dfe82972"><gtr:id>0737bcb5a8ebef94755f6214dfe82972</gtr:id><gtr:otherNames>Tripathi VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>pm_540e16ae16aa32be5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9E07BDB-0D6E-4ED8-A45F-158774CC81BE</gtr:id><gtr:title>The Identification of Aluminum in Human Brain Tissue Using Lumogallion and Fluorescence Microscopy.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90b2074f1fe9a5ca4a0b13a591e9efd5"><gtr:id>90b2074f1fe9a5ca4a0b13a591e9efd5</gtr:id><gtr:otherNames>Mirza A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>58db930f250f28.08177539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>041592A5-499A-4476-9FF4-9AB4ECADBDEB</gtr:id><gtr:title>Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e4d0cac119354bd44fe812e64bb8a75"><gtr:id>2e4d0cac119354bd44fe812e64bb8a75</gtr:id><gtr:otherNames>Tiwari SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>58db930fb42743.72515288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D474A5E-9396-4768-AB48-2A56BCDEE018</gtr:id><gtr:title>On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdad216ec928b21b8608a8e39b74026"><gtr:id>bcdad216ec928b21b8608a8e39b74026</gtr:id><gtr:otherNames>Sala Frigerio C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>58db94359bd582.46959532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95A003AB-C51A-4A94-AC3D-BE6176C6FC35</gtr:id><gtr:title>Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation.</gtr:title><gtr:parentPublicationTitle>Frontiers in psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3457936797ccbfd7d9ba22f0029cdf0e"><gtr:id>3457936797ccbfd7d9ba22f0029cdf0e</gtr:id><gtr:otherNames>Young AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1664-0640</gtr:issn><gtr:outcomeId>pm_16099_29_21629840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A68B6400-2B06-4B86-9B3F-2AC9A53D5AAB</gtr:id><gtr:title>Depression and synaptic zinc regulation in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia.</gtr:title><gtr:parentPublicationTitle>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373ede94ea3c44d7eca786be0b2c1d90"><gtr:id>373ede94ea3c44d7eca786be0b2c1d90</gtr:id><gtr:otherNames>Whitfield DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1064-7481</gtr:issn><gtr:outcomeId>5462193f64eff5.80492797</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57E24B0C-7D9D-417A-951B-89814E2440C3</gtr:id><gtr:title>Compromised paraspeckle formation as a pathogenic factor in FUSopathies.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1a410013657f0eb066eef4168175c03"><gtr:id>e1a410013657f0eb066eef4168175c03</gtr:id><gtr:otherNames>Shelkovnikova TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5462193fb18370.60456415</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EFD7C65-72E5-4DF5-BF67-37D995218C86</gtr:id><gtr:title>Epigenomic and transcriptomic signatures of a Klinefelter syndrome (47,XXY) karyotype in the brain.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6db2fe278c34aa6de97b6a6e12cafcdb"><gtr:id>6db2fe278c34aa6de97b6a6e12cafcdb</gtr:id><gtr:otherNames>Viana J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn><gtr:outcomeId>5462193f8cd9a8.34458030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1D8D1CB-A4FA-4D97-BDC8-D7138A101C1C</gtr:id><gtr:title>Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/151951d3745907b1f10418e7df3fe35c"><gtr:id>151951d3745907b1f10418e7df3fe35c</gtr:id><gtr:otherNames>Condliffe D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>54621ae2b87ed5.35415851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6013490B-CDB2-414E-AB49-7D46FEF34325</gtr:id><gtr:title>An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline.</gtr:title><gtr:parentPublicationTitle>Neuropathology : official journal of the Japanese Society of Neuropathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddda41cb956f24e278d3fa4457b83ecb"><gtr:id>ddda41cb956f24e278d3fa4457b83ecb</gtr:id><gtr:otherNames>Troakes C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0919-6544</gtr:issn><gtr:outcomeId>pm_16099_29_22181065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB8A023A-BC6D-4D49-A8B0-6AA2A15985DE</gtr:id><gtr:title>Clusterin expression is upregulated following acute head injury and localizes to astrocytes in old head injury.</gtr:title><gtr:parentPublicationTitle>Neuropathology : official journal of the Japanese Society of Neuropathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddda41cb956f24e278d3fa4457b83ecb"><gtr:id>ddda41cb956f24e278d3fa4457b83ecb</gtr:id><gtr:otherNames>Troakes C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0919-6544</gtr:issn><gtr:outcomeId>58db9310670ed1.87987300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A71EEF8-1CE2-489F-B89B-D281EBB933F7</gtr:id><gtr:title>Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52940ec2fe08219598d16e61c9f32c80"><gtr:id>52940ec2fe08219598d16e61c9f32c80</gtr:id><gtr:otherNames>Niblock M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>58db93123291b0.67759880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2BEABF3-25CC-4CD4-982F-9647E60A518B</gtr:id><gtr:title>Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/260fa42b858aee5033974fabe5a89dd6"><gtr:id>260fa42b858aee5033974fabe5a89dd6</gtr:id><gtr:otherNames>King A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_16099_29_23053136</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCB66D99-0897-44F8-8642-C6C02E2BC04B</gtr:id><gtr:title>Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>54621f8365a556.38826641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7E0C012-4400-4C1E-BD48-0F0D9D41FD4A</gtr:id><gtr:title>Atypical progressive supranuclear palsy presenting as primary lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/260fa42b858aee5033974fabe5a89dd6"><gtr:id>260fa42b858aee5033974fabe5a89dd6</gtr:id><gtr:otherNames>King A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>54621f83141244.44476033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8483F837-744D-4714-AA96-B59AE45D5923</gtr:id><gtr:title>C1q, the classical complement pathway protein binds Hirano bodies in Pick's disease.</gtr:title><gtr:parentPublicationTitle>Microscopy research and technique</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/511bb96ba512fd229aad4caa1376e8c5"><gtr:id>511bb96ba512fd229aad4caa1376e8c5</gtr:id><gtr:otherNames>Singhrao SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-910X</gtr:issn><gtr:outcomeId>54621ce3c7b2a4.89506577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D325E60C-D820-4BD8-AAF7-734E41043C59</gtr:id><gtr:title>The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>544bcf013e1c05.46260780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6043B3B-6F17-4579-AE4E-3BE92B643D2E</gtr:id><gtr:title>Clusterin associates specifically with A?40 in Alzheimer's disease brain tissue.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1da287f55a621cd5e9876bc34531117"><gtr:id>e1da287f55a621cd5e9876bc34531117</gtr:id><gtr:otherNames>Howlett DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>54621f833ebf46.88567242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E6F2D9D-F4ED-4BD9-9FA9-D49B5BA6288F</gtr:id><gtr:title>Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c831250c6d5af43302dbd12e99b4fb6"><gtr:id>1c831250c6d5af43302dbd12e99b4fb6</gtr:id><gtr:otherNames>Lee YB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_540e16ae16a8e0adb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBF8417F-BB77-4AE5-B452-4AB8A59F104C</gtr:id><gtr:title>Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a6cc6506e286a887cb628372a6d337e"><gtr:id>2a6cc6506e286a887cb628372a6d337e</gtr:id><gtr:otherNames>Davies MN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_16099_29_22703893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC5C5209-EE8F-4D34-9CCC-7AFA1DA24934</gtr:id><gtr:title>Epigenetic and genetic variation at the IGF2/H19 imprinting control region on 11p15.5 is associated with cerebellum weight.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cd860059da8333022783d0f25c6f76b"><gtr:id>6cd860059da8333022783d0f25c6f76b</gtr:id><gtr:otherNames>Pidsley R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn><gtr:outcomeId>pm_16099_29_22395465</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1170755-BE61-4473-B419-DC6D0E1F9D24</gtr:id><gtr:title>ATXN2 trinucleotide repeat length correlates with risk of ALS.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdc6e29ff1fbfb82d08db9aa811d9c11"><gtr:id>fdc6e29ff1fbfb82d08db9aa811d9c11</gtr:id><gtr:otherNames>Sproviero W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5aa699e29b59d1.36739737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A76BE152-1CFF-4409-A8A0-2D3D3595F5C8</gtr:id><gtr:title>The genetics and neuropathology of amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7bc8538c82db76d6e2482ddeeb2d3d0"><gtr:id>d7bc8538c82db76d6e2482ddeeb2d3d0</gtr:id><gtr:otherNames>Al-Chalabi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_16099_29_22903397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68E93E37-CE57-44FE-89A8-0D35D1414CB2</gtr:id><gtr:title>LRRK2 exonic variants and risk of multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d05ae276ba007db1461e7f91f861892"><gtr:id>4d05ae276ba007db1461e7f91f861892</gtr:id><gtr:otherNames>Heckman MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54621f83af1f29.23211234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0354C457-454C-40A9-ABAB-F8AC472154FF</gtr:id><gtr:title>Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e75e3b3ba79991d679d14b7a06170f9b"><gtr:id>e75e3b3ba79991d679d14b7a06170f9b</gtr:id><gtr:otherNames>Kurbatskaya K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>58db9311c90b05.34891302</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31C8A34C-4888-434F-813D-14DB6FD78D11</gtr:id><gtr:title>Genome-wide significant schizophrenia risk variation on chromosome 10q24 is associated with altered cis-regulation of BORCS7, AS3MT, and NT5C2 in the human brain.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d182f9c5c19fb926bfa186a131dc784"><gtr:id>7d182f9c5c19fb926bfa186a131dc784</gtr:id><gtr:otherNames>Duarte RRR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>58db931206a5c5.76647899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B45EC2D-D86D-4692-A6A5-3210D1B08C39</gtr:id><gtr:title>Influence of Coding Variability in APP-A? Metabolism Genes in Sporadic Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc6f5d980b9f26a631bb27b333a684ff"><gtr:id>fc6f5d980b9f26a631bb27b333a684ff</gtr:id><gtr:otherNames>Sassi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58db93116bb280.55118471</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B699066-2795-4613-9FF1-4F3A5ECECDDC</gtr:id><gtr:title>NEK1 variants confer susceptibility to amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa8dc20d96363a2f4e574a132c76feaf"><gtr:id>aa8dc20d96363a2f4e574a132c76feaf</gtr:id><gtr:otherNames>Kenna KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58db93102fe8b5.25283602</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E12D844F-CAF3-4EA0-AF29-B6B8C2AFFFFB</gtr:id><gtr:title>A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac5f45d8a5f9965eb360b3f6697fe0a9"><gtr:id>ac5f45d8a5f9965eb360b3f6697fe0a9</gtr:id><gtr:otherNames>Akimoto C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>544bcf03a36e01.94761814</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B1C23F1-918A-4956-92EF-85ED1F055A99</gtr:id><gtr:title>Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5fd8a036b6ccf0bb9a8fec23f69321d"><gtr:id>f5fd8a036b6ccf0bb9a8fec23f69321d</gtr:id><gtr:otherNames>Cruchaga C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>54621ae29076f8.06676020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7893C41F-2378-41E2-8908-420A8AEC5F9E</gtr:id><gtr:title>No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc23875dbdf591dfec98dd2283598bc3"><gtr:id>cc23875dbdf591dfec98dd2283598bc3</gtr:id><gtr:otherNames>Goris A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>544bcf0257e9b7.52663862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25DA8DC5-6565-482F-82DF-6F4322A2ADF2</gtr:id><gtr:title>Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cd860059da8333022783d0f25c6f76b"><gtr:id>6cd860059da8333022783d0f25c6f76b</gtr:id><gtr:otherNames>Pidsley R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58de6a6c14c350.72562711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FB14768-DDE3-4905-8650-A42CE791FBD2</gtr:id><gtr:title>The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9aa73e328eb61ebd7307a45f0b5976b5"><gtr:id>9aa73e328eb61ebd7307a45f0b5976b5</gtr:id><gtr:otherNames>Martin S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>5aa699e4e53521.11586011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>705AAF57-172A-47F1-9A2F-74B99999DCB5</gtr:id><gtr:title>A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa2841aab396cd2b4f18a94e7a29ae23"><gtr:id>aa2841aab396cd2b4f18a94e7a29ae23</gtr:id><gtr:otherNames>Morgan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aa699e3d49b28.83252519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48425377-AB01-44DC-B910-127579285D61</gtr:id><gtr:title>Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a68fd5b1ddbc5cb477a04d8d9b44b0b"><gtr:id>3a68fd5b1ddbc5cb477a04d8d9b44b0b</gtr:id><gtr:otherNames>?talekar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>56d462377e5135.87427190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11AF9882-337B-4F5E-A966-3798CF668B3D</gtr:id><gtr:title>Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18061332c54aaf54ab04a4a898d17ccc"><gtr:id>18061332c54aaf54ab04a4a898d17ccc</gtr:id><gtr:otherNames>Gomez-Deza J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56d46238c9a2f3.14235257</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F24DCD53-4294-49EF-A148-255059CBE1C9</gtr:id><gtr:title>Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b25414b7949c1dc388472b22a5fd011"><gtr:id>7b25414b7949c1dc388472b22a5fd011</gtr:id><gtr:otherNames>Robinson AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>58db930ea85e81.31688904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78B8C15E-C24F-4073-8ACC-6D13332D2720</gtr:id><gtr:title>Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c8d2dccb5c3338979e7f8a8641956f6"><gtr:id>0c8d2dccb5c3338979e7f8a8641956f6</gtr:id><gtr:otherNames>Proitsi P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_16099_29_24064185</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C133660E-F77E-4531-910C-3825CC353EB5</gtr:id><gtr:title>Functional and genetic analysis of haplotypic sequence variation at the nicastrin genomic locus.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c3d9dd16ce35d2096b37dfc9199bc7"><gtr:id>69c3d9dd16ce35d2096b37dfc9199bc7</gtr:id><gtr:otherNames>Hamilton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_16099_29_22405046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B93DA1D-850C-44CB-A3C4-329E01545958</gtr:id><gtr:title>Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc6f5d980b9f26a631bb27b333a684ff"><gtr:id>fc6f5d980b9f26a631bb27b333a684ff</gtr:id><gtr:otherNames>Sassi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>54621ae1b98532.14795021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FB5BE84-4F8C-46CB-B91F-B23A81DFF302</gtr:id><gtr:title>Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a439e3cead6e102b8a7c8e439170b4fb"><gtr:id>a439e3cead6e102b8a7c8e439170b4fb</gtr:id><gtr:otherNames>Wei W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>58db930e1493d5.88214657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>193D0A48-A05C-4319-BCDB-7CC096458B9B</gtr:id><gtr:title>Control tissue in brain banking: the importance of thorough neuropathological assessment.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9963f5dfef08ff2e5046f8167ff09f18"><gtr:id>9963f5dfef08ff2e5046f8167ff09f18</gtr:id><gtr:otherNames>Nolan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>58db9436b3c226.52524225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E7BBA7F-7C40-4FC3-A29A-CF2167411CFC</gtr:id><gtr:title>Autosomal dominant inheritance of rapidly progressive amyotrophic lateral sclerosis due to a truncation mutation in the fused in sarcoma (FUS) gene.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4764aa823b7a020b3590bce2cc799303"><gtr:id>4764aa823b7a020b3590bce2cc799303</gtr:id><gtr:otherNames>Kent L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>544bcf045a5fe5.17451079</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F822967-A2B1-49BA-9BFF-F43372C6C8B6</gtr:id><gtr:title>Stratified gene expression analysis identifies major amyotrophic lateral sclerosis genes.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/189b1ab3fec05c8e5670388f3356335d"><gtr:id>189b1ab3fec05c8e5670388f3356335d</gtr:id><gtr:otherNames>Jones AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56d46237ac4964.75802103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>006CDAA1-D714-4FBF-B2EB-7437A612815B</gtr:id><gtr:title>Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5cb5ee1cb3ef9a2866a69a8f48935cc"><gtr:id>f5cb5ee1cb3ef9a2866a69a8f48935cc</gtr:id><gtr:otherNames>Adler-Abramovich L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>pm_16099_29_22706200</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DA1EA55-0571-4C6E-8F43-4CA7DDABC020</gtr:id><gtr:title>Aluminium in brain tissue in familial Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90b2074f1fe9a5ca4a0b13a591e9efd5"><gtr:id>90b2074f1fe9a5ca4a0b13a591e9efd5</gtr:id><gtr:otherNames>Mirza A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0946-672X</gtr:issn><gtr:outcomeId>58db930dbeff96.49943160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEB8DCCB-CAEB-4E14-BD6B-F643D25A505E</gtr:id><gtr:title>Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f5ee2d92393641a7087d03d8fb52781"><gtr:id>2f5ee2d92393641a7087d03d8fb52781</gtr:id><gtr:otherNames>Scotter EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>544bcf02dec130.64984146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1B853E4-0A9E-4D86-9128-FAFE40066051</gtr:id><gtr:title>The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7a435c099f51c22c978c2952fedec72"><gtr:id>f7a435c099f51c22c978c2952fedec72</gtr:id><gtr:otherNames>Respondek G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>54621f838c1c78.00475650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E3CAAC8-BFAE-4FC4-A930-C650112E9DA6</gtr:id><gtr:title>Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93dc99c98b59b49150ea537d5c4c070a"><gtr:id>93dc99c98b59b49150ea537d5c4c070a</gtr:id><gtr:otherNames>Diekstra FP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>544bcf00f13c98.09263733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>788D2E68-AFFC-44AA-8A39-E509686F4B24</gtr:id><gtr:title>Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c3f5a5bc7ae9744e72b93546e48cb6f"><gtr:id>7c3f5a5bc7ae9744e72b93546e48cb6f</gtr:id><gtr:otherNames>Ahmeti KB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>544bcf016e38a3.28501419</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81F2D608-9C21-4AD6-92CF-B6A9BFFB7F31</gtr:id><gtr:title>Tissue-specific patterns of allelically-skewed DNA methylation.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7b52dfa2214239ad8f998a9194da81c"><gtr:id>a7b52dfa2214239ad8f998a9194da81c</gtr:id><gtr:otherNames>Marzi SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn><gtr:outcomeId>58db9432e754c2.55061662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90C4EB4C-EA24-4C2B-BE4C-FB94F36FFAF9</gtr:id><gtr:title>Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphisms.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a459785bc0c5e7e684c966ef9ae36897"><gtr:id>a459785bc0c5e7e684c966ef9ae36897</gtr:id><gtr:otherNames>Cardo LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>54621bdab25220.12139832</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2286241E-DAFA-4E9C-9550-301DDCE9B311</gtr:id><gtr:title>Gamma-synuclein pathology in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd53cac0abf325e035a3f235ae534c0a"><gtr:id>fd53cac0abf325e035a3f235ae534c0a</gtr:id><gtr:otherNames>Peters OM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>58db94371236d1.48488495</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62FAEE75-D1C4-4CC9-A222-9E06AA89AF16</gtr:id><gtr:title>Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8589a7315a7ba0fad1154b0030273cf"><gtr:id>c8589a7315a7ba0fad1154b0030273cf</gtr:id><gtr:otherNames>Kovacs GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>pm_16099_29_22471883</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CDBCF5D-D6EC-495B-B3EB-F86AEFBDAB8B</gtr:id><gtr:title>A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68ae0b5920edebc0579f77ebe7ddbb4e"><gtr:id>68ae0b5920edebc0579f77ebe7ddbb4e</gtr:id><gtr:otherNames>Fogh I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>544bcf02883315.60737102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F046261-1912-483C-A0B3-6CD311408061</gtr:id><gtr:title>Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a7bfa806ecaa3aa93efd2103aa2e758"><gtr:id>0a7bfa806ecaa3aa93efd2103aa2e758</gtr:id><gtr:otherNames>Cirulli ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>58db9436697046.12768477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>092AD552-4F6A-4EE7-A756-852D94D5B1D5</gtr:id><gtr:title>Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73a8bd121700732d13322b944eaf8dff"><gtr:id>73a8bd121700732d13322b944eaf8dff</gtr:id><gtr:otherNames>Hannon E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>58db9433881e53.80182260</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9388511B-534A-4B6B-AADD-9D6CB32E6BAF</gtr:id><gtr:title>Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Current Alzheimer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f13e80e53c033662ade1364c160bea0"><gtr:id>9f13e80e53c033662ade1364c160bea0</gtr:id><gtr:otherNames>Gersch?tz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1567-2050</gtr:issn><gtr:outcomeId>pm_16099_29_24156256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39A93625-CAE0-408E-8A96-DCE9E7CAB8D6</gtr:id><gtr:title>The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e376c7bbd418afdca53888c2c81e747"><gtr:id>4e376c7bbd418afdca53888c2c81e747</gtr:id><gtr:otherNames>Cocks G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>54621bda8d4587.18767196</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F689969-2B9C-4BF0-AB2D-77C9998E6862</gtr:id><gtr:title>ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77bcf36f991f182856eac148a0a0aa02"><gtr:id>77bcf36f991f182856eac148a0a0aa02</gtr:id><gtr:otherNames>Stoica R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>544bcf042f8d38.13230496</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69E8FC3E-966F-4FCF-A32D-F14A946AAB5A</gtr:id><gtr:title>C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93dc99c98b59b49150ea537d5c4c070a"><gtr:id>93dc99c98b59b49150ea537d5c4c070a</gtr:id><gtr:otherNames>Diekstra FP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>544bcf04854020.50255754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E030A186-AE97-459C-9EBE-E89786AAB438</gtr:id><gtr:title>Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd1ac80b42e880cbd4857157a6fb016d"><gtr:id>dd1ac80b42e880cbd4857157a6fb016d</gtr:id><gtr:otherNames>Davidson Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>58db9433b95701.35768103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8290B069-F5DC-4B45-83EF-23B23F8D998C</gtr:id><gtr:title>Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7a435c099f51c22c978c2952fedec72"><gtr:id>f7a435c099f51c22c978c2952fedec72</gtr:id><gtr:otherNames>Respondek G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_16099_29_23436751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>684A5C65-0D7A-4832-9BD1-BD9DDAABA864</gtr:id><gtr:title>Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_16099_29_23434116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03859F21-08A5-4EFD-8C7C-A018770C36FB</gtr:id><gtr:title>Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58db9433357043.62478294</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D77E280-E1EF-4604-8204-A8A30452835D</gtr:id><gtr:title>Erratum to: Variation in 5-hydroxymethylcytosine across human cortex and cerebellum.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/878e2d05b1e177f10ea100a84346398f"><gtr:id>878e2d05b1e177f10ea100a84346398f</gtr:id><gtr:otherNames>Lunnon K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58db931110a9f6.72018899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74D5F549-A882-44DA-A4B1-62719775816D</gtr:id><gtr:title>A comparison of mitochondrial DNA isolation methods in frozen post-mortem human brain tissue--applications for studies of mitochondrial genetics in brain disorders.</gtr:title><gtr:parentPublicationTitle>BioTechniques</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2e3c28d30fd7f5224a384b7f7c3280d"><gtr:id>d2e3c28d30fd7f5224a384b7f7c3280d</gtr:id><gtr:otherNames>Devall M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0736-6205</gtr:issn><gtr:outcomeId>58db9434431148.16434961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3965CCD4-7957-4C42-BAC5-028791DA4861</gtr:id><gtr:title>CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11558ca688574360e413c95a4ca96865"><gtr:id>11558ca688574360e413c95a4ca96865</gtr:id><gtr:otherNames>Solas M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>54621bdb235676.50811727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79AB875E-CEAA-4D13-9DF1-ED101C4E35A7</gtr:id><gtr:title>Prostate-derived sterile 20-like kinases (PSKs/TAOKs) phosphorylate tau protein and are activated in tangle-bearing neurons in Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ecb9f33db573c75e67576d2e96282ead"><gtr:id>ecb9f33db573c75e67576d2e96282ead</gtr:id><gtr:otherNames>Tavares IA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_16099_29_23585562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFE1050D-08B8-47A3-BA14-A4F7BE0B8692</gtr:id><gtr:title>Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b237e1dd0d5ded53e55bf78ceb3cb1b3"><gtr:id>b237e1dd0d5ded53e55bf78ceb3cb1b3</gtr:id><gtr:otherNames>Davidson YS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>54621ae269af06.40132454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CF25590-6548-4830-A669-3891BB6F28D2</gtr:id><gtr:title>Variation in 5-hydroxymethylcytosine across human cortex and cerebellum.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/878e2d05b1e177f10ea100a84346398f"><gtr:id>878e2d05b1e177f10ea100a84346398f</gtr:id><gtr:otherNames>Lunnon K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58db94328d0a90.99654685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C920CBA-22DE-491A-BC90-2FA1CD552DCD</gtr:id><gtr:title>The CHCHD10 P34S variant is not associated with ALS in a UK cohort of familial and sporadic patients.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a1becffcc1571868d22b707ce216d4c"><gtr:id>5a1becffcc1571868d22b707ce216d4c</gtr:id><gtr:otherNames>Wong CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58db9434c82d84.62812802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>666EB570-A38B-4233-9988-8659BE86F146</gtr:id><gtr:title>Comment on &amp;quot;Drug screening for ALS using patient-specific induced pluripotent stem cells&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0033dc734f06165d7061a9236c4adef"><gtr:id>c0033dc734f06165d7061a9236c4adef</gtr:id><gtr:otherNames>Bilican B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>544bcf01f119e7.52699369</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2033D773-9D67-4F99-88E4-7F32F8EC6AEF</gtr:id><gtr:title>RNA Misprocessing in-Linked Neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Frontiers in cellular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9adb0cf9c748d2062adf63457cc15ba4"><gtr:id>9adb0cf9c748d2062adf63457cc15ba4</gtr:id><gtr:otherNames>Barker HV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1662-5102</gtr:issn><gtr:outcomeId>5aa699e5738790.24080771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED031620-00E6-4376-9F89-277CEB635E0B</gtr:id><gtr:title>Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer's disease progression: CX3CL1, TREM2, and PPAR?.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0ad4e84d65dad22eb32a52aa7530c3f"><gtr:id>d0ad4e84d65dad22eb32a52aa7530c3f</gtr:id><gtr:otherNames>Strobel S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>58db94379e9ca3.26713580</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3093243D-169E-47CD-A895-FDE95134E836</gtr:id><gtr:title>Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddda41cb956f24e278d3fa4457b83ecb"><gtr:id>ddda41cb956f24e278d3fa4457b83ecb</gtr:id><gtr:otherNames>Troakes C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>pm_16099_29_22934812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DAE0DE3-C55F-4782-906C-E35931E23DBF</gtr:id><gtr:title>Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ecfd0497d0375c0a88359b331f4d279"><gtr:id>6ecfd0497d0375c0a88359b331f4d279</gtr:id><gtr:otherNames>Alami NH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>544bcf031799a2.08217536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCFBFEF6-E394-4AC4-8B14-0E69D80BB5B9</gtr:id><gtr:title>ABCA7 p.G215S as potential protective factor for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc6f5d980b9f26a631bb27b333a684ff"><gtr:id>fc6f5d980b9f26a631bb27b333a684ff</gtr:id><gtr:otherNames>Sassi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58db93113dea19.82116291</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7664F9D5-1E85-47A4-9611-6402C168EAB3</gtr:id><gtr:title>Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9da89c318f56fc7256d9d74b60d23229"><gtr:id>9da89c318f56fc7256d9d74b60d23229</gtr:id><gtr:otherNames>Sims R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5aa699e46a4a55.51168519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DCAB2B0-06C7-4C5E-965E-DAC68AC07D98</gtr:id><gtr:title>TREM2 variants in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_16099_29_23150934</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E09F55E-186A-4464-A9E6-65E8846C6516</gtr:id><gtr:title>Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90509523adb96ea1aa3696ac87c9450d"><gtr:id>90509523adb96ea1aa3696ac87c9450d</gtr:id><gtr:otherNames>Smith BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>5aa699e3687533.67844697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACA591F3-E203-4DBF-B897-51C8E5963CFC</gtr:id><gtr:title>Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/878e2d05b1e177f10ea100a84346398f"><gtr:id>878e2d05b1e177f10ea100a84346398f</gtr:id><gtr:otherNames>Lunnon K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>54621ae1e15a81.10904411</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9708042A-B268-482B-A4EE-33A03CC5EB33</gtr:id><gtr:title>Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc6f5d980b9f26a631bb27b333a684ff"><gtr:id>fc6f5d980b9f26a631bb27b333a684ff</gtr:id><gtr:otherNames>Sassi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>54621ae1948334.22654408</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E857CFA4-CE59-4057-906F-6086AF7F6DF8</gtr:id><gtr:title>Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/761359f3f7fbaff4c99cbe26f80ed1b9"><gtr:id>761359f3f7fbaff4c99cbe26f80ed1b9</gtr:id><gtr:otherNames>Vidal B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>58db93119bd797.44705015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52B70195-A14F-4565-B417-8135D4F4EE66</gtr:id><gtr:title>Identification of Alzheimer disease risk genotype that predicts efficiency of SORL1 expression in the brain.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dae328a36065d36e8649f9e6648ef2d"><gtr:id>1dae328a36065d36e8649f9e6648ef2d</gtr:id><gtr:otherNames>Caglayan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>pm_16099_29_22410445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74010AB5-7247-48AE-9848-05228C2766F4</gtr:id><gtr:title>ALS-FUS pathology revisited: singleton FUS mutations and an unusual case with both a FUS and TARDBP mutation.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/260fa42b858aee5033974fabe5a89dd6"><gtr:id>260fa42b858aee5033974fabe5a89dd6</gtr:id><gtr:otherNames>King A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56d46239d884c7.36960805</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21E18855-B65B-40A1-BBEA-DA25C96824FE</gtr:id><gtr:title>Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a46cc13f73dd87b9293e1cd22958c7c"><gtr:id>6a46cc13f73dd87b9293e1cd22958c7c</gtr:id><gtr:otherNames>Stepto A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_540e16ae16a979aa1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3700700-D813-4CF4-AB95-B739F9AD1F85</gtr:id><gtr:title>Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1da287f55a621cd5e9876bc34531117"><gtr:id>e1da287f55a621cd5e9876bc34531117</gtr:id><gtr:otherNames>Howlett DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>54621ae2181860.93665826</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>101E5CEC-D758-4AEF-808A-8ED0BFF83325</gtr:id><gtr:title>Phosphorylation of C-terminal tyrosine residue 526 in FUS impairs its nuclear import.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29bb14781cddeeb34ff38065851a6ba1"><gtr:id>29bb14781cddeeb34ff38065851a6ba1</gtr:id><gtr:otherNames>Darovic S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>56d46239a7cf84.98641392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B92FB35B-8E8F-45CA-AB70-92B733BC9D1F</gtr:id><gtr:title>A data-driven approach to preprocessing Illumina 450K methylation array data.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cd860059da8333022783d0f25c6f76b"><gtr:id>6cd860059da8333022783d0f25c6f76b</gtr:id><gtr:otherNames>Pidsley R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>54621da6880a60.99260469</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>265790A3-068E-4BA4-A3D1-8DB5D4023544</gtr:id><gtr:title>Neuromuscular disease: new insights and avenues for therapy.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f5ee2d92393641a7087d03d8fb52781"><gtr:id>2f5ee2d92393641a7087d03d8fb52781</gtr:id><gtr:otherNames>Scotter EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>544bcf019cb4a7.27593700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67F69F70-8475-41A7-A28B-D28550DD2A08</gtr:id><gtr:title>ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/107e692c5cbfdd08a4bdfa319afca3cb"><gtr:id>107e692c5cbfdd08a4bdfa319afca3cb</gtr:id><gtr:otherNames>Vance C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_16099_29_23474818</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89212411-18BE-4502-92F6-12CAC48E66C6</gtr:id><gtr:title>Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>58db930e7963a4.48753769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23A609EF-63CB-4D22-99F7-B54F25627B98</gtr:id><gtr:title>Lack of association between TDP-43 pathology and tau mis-splicing in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52940ec2fe08219598d16e61c9f32c80"><gtr:id>52940ec2fe08219598d16e61c9f32c80</gtr:id><gtr:otherNames>Niblock M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56d4623a192be3.89588407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA3E77AA-B26B-416E-866A-05017E154DA2</gtr:id><gtr:title>Assessment of the degree of asymmetry of pathological features in neurodegenerative diseases. What is the significance for brain banks?</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/260fa42b858aee5033974fabe5a89dd6"><gtr:id>260fa42b858aee5033974fabe5a89dd6</gtr:id><gtr:otherNames>King A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>58db943562b5d5.22148245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55FDE076-FF77-4D35-B2A0-84891F428F90</gtr:id><gtr:title>Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46e73b422d17d863d689d21fb0a952eb"><gtr:id>46e73b422d17d863d689d21fb0a952eb</gtr:id><gtr:otherNames>Kun-Rodrigues C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58db930f88aef4.00744299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99BB4301-92DE-4789-95E1-9F0B25BF3FE3</gtr:id><gtr:title>C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32f0eec9d99a9f9c30f1d78b95480322"><gtr:id>32f0eec9d99a9f9c30f1d78b95480322</gtr:id><gtr:otherNames>Mizielinska S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>54621da6adecb5.63934135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9D9556E-32FF-4FFD-B16C-E14F257D2690</gtr:id><gtr:title>Neuron-specific alterations in signal transduction pathways associated with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f13e80e53c033662ade1364c160bea0"><gtr:id>9f13e80e53c033662ade1364c160bea0</gtr:id><gtr:otherNames>Gersch?tz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>54621ae24123a5.65574335</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BEB4A3A-7508-49FB-AE78-A0E670968B1C</gtr:id><gtr:title>Schizophrenia-associated methylomic variation: molecular signatures of disease and polygenic risk burden across multiple brain regions.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6db2fe278c34aa6de97b6a6e12cafcdb"><gtr:id>6db2fe278c34aa6de97b6a6e12cafcdb</gtr:id><gtr:otherNames>Viana J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>58db930e47d068.86466232</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0C8685E-EA89-4627-A123-19534F541202</gtr:id><gtr:title>An evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALS.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3108c31a0519408ba70fe51961bbba10"><gtr:id>3108c31a0519408ba70fe51961bbba10</gtr:id><gtr:otherNames>Savage AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>544bcf03736d30.04611140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EFBB64D-CD3C-403F-A35F-B2245E57516D</gtr:id><gtr:title>Unpicking neurodegeneration in a dish with human pluripotent stem cells: one cell type at a time.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0033dc734f06165d7061a9236c4adef"><gtr:id>c0033dc734f06165d7061a9236c4adef</gtr:id><gtr:otherNames>Bilican B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>544bcf0229e0f0.81404388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19EBABC7-7AE6-4BB1-98BB-67E0279A4317</gtr:id><gtr:title>Evidence that the presynaptic vesicle protein CSPalpha is a key player in synaptic degeneration and protection in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Molecular brain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e4d0cac119354bd44fe812e64bb8a75"><gtr:id>2e4d0cac119354bd44fe812e64bb8a75</gtr:id><gtr:otherNames>Tiwari SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1756-6606</gtr:issn><gtr:outcomeId>58db943742ad43.85802910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B3BD6AF-467A-4EDD-9D1B-A928C4A4A572</gtr:id><gtr:title>Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aaff144eb8c549f75ef3e66c1e865ad2"><gtr:id>aaff144eb8c549f75ef3e66c1e865ad2</gtr:id><gtr:otherNames>Mitchell JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56d462387668a0.03122193</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1100695</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>